换一批
换一批新起之秀,Birabresib(OTX015/MK-8628)通过抑制BET蛋白靶向治疗NUT癌等晚期实体瘤
A Rising Star,Birabresib(MK-8628)Targets Advanced Solid Tumors Including NUT Carcinoma by Inhibiting Bromodomain and Extraterminal Proteins
摘要1 文献来源LEWIN J,SORIA J C,STATHIS A,et al.PhaseⅠb trial with birabresib,a small-molecule inhibitor of bromodomain and extraterminal proteins,in patients with selected advanced solid tumors[J].J Clin Oncol,2018,36(30):3007-3014.doi:10.1200/JCO.2018.78.2292.
更多相关知识
关键词
BirabresibBET蛋白NUT癌分子靶向治疗Birabresibbromodomain and extraterminal domainNUT carcinomamolecular targeted therapy
分类号
R730
栏目名称
循证评价
DOI
10.12019/j.issn.1671-5144.202410047
发布时间
2024-12-30
- 浏览4
- 被引0
- 下载0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
